Crescent Capital BDC (NASDAQ:CCAP) PT Raised to $19.00 at Keefe, Bruyette & Woods

Crescent Capital BDC (NASDAQ:CCAP) had its price objective lifted by Keefe, Bruyette & Woods from $18.50 to $19.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Keefe, Bruyette & Woods’ price target suggests a potential upside of 5.61% from the stock’s current price.

A number of other analysts also recently weighed in on the stock. Wells Fargo & Company increased their price target on shares of Crescent Capital BDC from $16.50 to $18.00 and gave the company an “equal weight” rating in a research report on Monday, May 13th. Raymond James raised their target price on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “outperform” rating in a report on Friday, May 10th. Finally, Oppenheimer raised their target price on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “outperform” rating in a report on Friday, February 23rd.

Crescent Capital BDC Stock Up 1.0 %

Shares of NASDAQ CCAP opened at $17.99 on Thursday. The firm has a market capitalization of $666.71 million, a PE ratio of 6.40 and a beta of 0.81. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.11. Crescent Capital BDC has a 1 year low of $13.37 and a 1 year high of $18.20. The firm’s 50-day moving average is $17.43 and its 200-day moving average is $17.02.

Crescent Capital BDC (NASDAQ:CCAP) last issued its earnings results on Wednesday, February 21st. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.57 by $0.04. The company had revenue of $50.00 million for the quarter, compared to analyst estimates of $47.99 million. Crescent Capital BDC had a net margin of 53.32% and a return on equity of 11.99%. Equities analysts expect that Crescent Capital BDC will post 2.34 EPS for the current year.

Hedge Funds Weigh In On Crescent Capital BDC

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. International Assets Investment Management LLC bought a new position in Crescent Capital BDC during the fourth quarter worth $1,254,000. Anchor Investment Management LLC bought a new stake in shares of Crescent Capital BDC in the fourth quarter valued at about $342,000. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Crescent Capital BDC in the third quarter valued at about $240,000. Sumitomo Mitsui Trust Holdings Inc. bought a new stake in shares of Crescent Capital BDC in the fourth quarter valued at about $843,000. Finally, Virtus ETF Advisers LLC boosted its position in shares of Crescent Capital BDC by 43.5% in the third quarter. Virtus ETF Advisers LLC now owns 40,965 shares of the company’s stock valued at $701,000 after acquiring an additional 12,420 shares during the period. 49.46% of the stock is owned by institutional investors.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.